There is little time left for TG Therapeutics Inc (TGTX) to reach its 1-year target estimate. How soon will it surpass it?
TG Therapeutics Inc (NASDAQ:TGTX) shares traded 6.04% higher at $16.69 on Wall Street last session. In accordance with the data, 9 analysts cover TG Therapeutics Inc (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $6.00, […]
Before You Invest In TG Therapeutics Inc (NASDAQ:TGTX), Consider This Metric
In yesterday’s Wall Street session, TG Therapeutics Inc (NASDAQ:TGTX) shares traded at $16.03, down -2.55% from the previous session. As of this writing, 9 analysts cover TG Therapeutics Inc (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a […]
Can TG Therapeutics Inc (TGTX) stock recover despite sales dropping?
The price of TG Therapeutics Inc (NASDAQ:TGTX) shares last traded on Wall Street rose 2.56% to $12.81. Based on available information, 9 analysts follow TG Therapeutics Inc (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a low of […]
There is little time left for TG Therapeutics Inc (TGTX) to reach its 1-year target estimate. How soon will it surpass it?
TG Therapeutics Inc (NASDAQ:TGTX) shares traded -3.90% lower at $12.32 on Wall Street last session. In accordance with the data, 9 analysts cover TG Therapeutics Inc (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $6.00, […]
Does TG Therapeutics Inc (NASDAQ:TGTX) warrant a purchase right now? What to Consider Before Making a Decision
The stock of TG Therapeutics Inc (NASDAQ:TGTX) last traded at $11.26, down -0.09% from the previous session. Data from the available sources indicates that TG Therapeutics Inc (NASDAQ:TGTX) is covered by 9 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
Why TG Therapeutics Inc (TGTX) Should Be On Your Radar Moving Forward
The stock of TG Therapeutics Inc (NASDAQ:TGTX) last traded at $10.83, up 5.66% from the previous session. Data from the available sources indicates that TG Therapeutics Inc (NASDAQ:TGTX) is covered by 9 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
The most important numbers to know about TG Therapeutics Inc (NASDAQ:TGTX)
The stock of TG Therapeutics Inc (NASDAQ:TGTX) last traded at $7.73, up 4.60% from the previous session. Data from the available sources indicates that TG Therapeutics Inc (NASDAQ:TGTX) is covered by 9 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
Stocks of TG Therapeutics Inc [TGTX] are gaining investors’ attention: here’s why
Stocks of TG Therapeutics Inc (NASDAQ:TGTX) traded higher last session on Wall Street, down -5.26% to $7.02. According to the data, TG Therapeutics Inc (NASDAQ:TGTX) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and […]
TG Therapeutics Inc. (TGTX) Holding Strong: What’s pushing it?
The price of TG Therapeutics Inc. (NASDAQ:TGTX) shares last traded on Wall Street fell -0.49% to $10.14. Based on available information, 9 analysts follow TG Therapeutics Inc. (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a low of […]
TG Therapeutics Inc. (TGTX) Price Aside, TGTX Fundamentals Booming Beyond Compare
In yesterday’s Wall Street session, TG Therapeutics Inc. (NASDAQ:TGTX) shares traded at $11.29, up 2.17% from the previous session. 9 analysts cover TG Therapeutics Inc. (NASDAQ:TGTX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a […]
